La maladie de Parkinson en France (serveur d'exploration) - Merge (PascalFrancis)

Index « FA11s1.i » - entrée « MARSDEN (C. D.) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
MARSAULT (C.) < MARSDEN (C. D.) < MARSDEN (J. F.)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
001417 (1990) R. Raisman-Vozari ; J.-A. Girault ; S. Moussaoui ; C. Feuerstein ; P. Jenner ; C. D. Marsden ; Y. AgidLack of change in triatal DARPP-32 levels following nigrostriatal dopaminergic lesions in animals and in parkinsonian syndromes in man
001433 (1990) D. T. Dexter ; A. Carayon ; M. Vidailhet ; M. Ruberg ; F. Agid ; Y. Agid ; A. J. Lees ; F. R. Wells ; P. Jenner ; C. D. MarsdenDecreased ferritin levels in brain in Parkinson's disease
001889 (1997) U. K. Rinne ; F. Bracco ; C. Chouza ; E. Dupont ; O. Gershanik ; J. F. Marti Masso ; J. L. Montastruc ; C. D. Marsden ; A. Dubini ; N. Orlando ; R. GrimaldiCabergoline in the treatment of early Parkinson's disease : Results of the first year of treatment in a double-blind comparison of cabergoline and levodopa
001942 (1997) V. Plante-Bordeneuve ; D. Taussig ; F. Thomas ; G. Said ; N. W. Wood ; C. D. Marsden ; A. E. HardingEvaluation of four candidate genes encoding proteins of the dopamine pathway in familial and sporadic Parkinson's disease : Evidence for association of a DRD2 allele
001A14 (1998) U. K. Rinne ; F. Bracco ; C. Chouza ; E. Dupont ; O. Gershanik ; J. F. Marti Masso ; J. L. Montastruc ; C. D. MarsdenEarly treatment of Parkinson's Disease with cabergoline delays the onset of motor complications: Results of a double-blind levodopa controlled trial
001A17 (1998) J. R. Vaughan ; M. J. Farrer ; Z. K. Wszolek ; T. Gasser ; A. Durr ; Y. Agid ; V. Bonifati ; G. Demichele ; G. Volpe ; S. Lincoln ; M. Breteler ; G. Meco ; A. Brice ; C. D. Marsden ; J. Hardy ; N. W. WoodSequencing of the α-synuclein gene in a large series of cases of familial Parkinson's disease fails to reveal any further mutations
001A63 (1998) J. Vaughan ; A. Durr ; J. Tassin ; B. Bereznai ; T. Gasset ; V. Bonifati ; G. De Michele ; E. Fabrizio ; G. Volpe ; O. Bandmann ; W. G. Johnson ; L. I. Golbe ; M. Breteler ; G. Meco ; Y. Agid ; A. Brice ; C. D. Marsden ; N. W. WoodThe α-synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease : A study of 230 European cases

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Merge
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i -k "MARSDEN (C. D.)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Merge/FA11s1.i  \
                -Sk "MARSDEN (C. D.)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Merge/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Merge
   |type=    indexItem
   |index=    FA11s1.i
   |clé=    MARSDEN (C. D.)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024